Founded in 1972, Eurofarma operates in the healthcare sector with the production and sale of products and services to improve people’s quality of life. Focused on generating shared value, it covers the main pharmaceutical segments, such as prescription, OTC and personal care, generics, hospital, oncology and animal health, in addition to providing production services to third parties. With a wide coverage of therapeutic classes, the portfolio comprises more than 2 thousand products and 3.7 thousand SKUs (presentations), serving the main medical specialties.
Leader in medical prescriptions in Latin America and Brazil, where it holds second place in generics, Eurofarma operates in 22 countries, with 100% coverage in Latin America and operations in the USA and Africa. It has 12,600 employees and 11 factories, with a total production of 573 million units in 2023. In the same year, it invested more than R$ 680 million in innovation and achieved total net revenue of R$ 9.1 billion. Over the last 15 years, Eurofarma has recorded an average annual growth of 17%.